✦ LIBER ✦

Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

✍ Scribed by Andrew M Stein, Giovanni Martinelli, Timothy P Hughes, Martin C Müller…

Book ID: 120679945
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 256 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-173

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular response to first line nilotin

Molecular response to first line nilotinib in a patient with e19a2 BCR–ABL1 chronic myeloid leukemia

✍ Stephen E. Langabeer; Sarah L. McCarron; Peig Carroll; Johanna Kelly; Michael O’ 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Adherence to treatment with second-line

Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia

✍ Yood, Marianne Ulcickas; Oliveria, Susan A.; Cziraky, Mark; Hirji, Ishan; Hamdan 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 206 KB

Impact of BCR-ABL mutations on response

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

✍ Mario Tiribelli, Roberto Latagliata, Luigiana Luciano… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 143 KB

Front-Line Therapy With Second-Generatio

Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?

✍ Jabbour, E.; Kantarjian, H. M.; O'Brien, S.; Shan, J.; Quintas-Cardama, A.; Garc 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 126 KB

Imatinib produces significantly superior

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

✍ Branford, S; Rudzki, Z; Harper, A; Grigg, A; Taylor, K; Durrant, S; Arthur, C; B 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 283 KB

A report of early cytogenetic response t

A report of early cytogenetic response to imatinib in two patients with chronic myeloid leukemia at accelerated phase and carrying the e19a2 BCR-ABL transcript

✍ Xiaoqing Li; Jing Yang; Xiangjun Chen; Jun Liu; Hongrui Li; Jine Zheng; Yanli He 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 429 KB